Regulation of the Lewis Blood Group Antigen Expression: A Literature Review Supplemented with Computational Analysis.

Gene regulation Lewis blood group Transcription Transcription factors Translation

Journal

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie
ISSN: 1660-3796
Titre abrégé: Transfus Med Hemother
Pays: Switzerland
ID NLM: 101176417

Informations de publication

Date de publication:
Aug 2024
Historique:
received: 27 11 2023
accepted: 11 04 2024
medline: 13 8 2024
pubmed: 13 8 2024
entrez: 13 8 2024
Statut: epublish

Résumé

The Lewis (Le) blood group system, unlike most other blood groups, is not defined by antigens produced internally to the erythrocytes and their precursors but rather by glycan antigens adsorbed on to the erythrocyte membrane from the plasma. These oligosaccharides are synthesized by the two fucosyltransferases To address this question, we screened existing literature and additionally used in silico prediction tools to identify novel candidate regulators for Understanding the regulation of The Lewis (Le) blood group system, in contrast to the majority of blood groups, is not able to synthesize its antigens itself. It depends on the attachment of different oligosaccharides to the erythrocyte membrane, which are adsorbed from the plasma. These glycans are modified by the fucosyltransferases 2 and 3 enzymes (FUT2/3). Beside their role in defining the Lewis blood group, FUT2 and FUT3 are also known to be involved in the susceptibility and progression of various gastrointestinal pathologies, like inflammatory bowel diseases (IBD) or colorectal cancer (CRC). Even though different expression levels of

Sections du résumé

Background UNASSIGNED
The Lewis (Le) blood group system, unlike most other blood groups, is not defined by antigens produced internally to the erythrocytes and their precursors but rather by glycan antigens adsorbed on to the erythrocyte membrane from the plasma. These oligosaccharides are synthesized by the two fucosyltransferases
Summary UNASSIGNED
To address this question, we screened existing literature and additionally used in silico prediction tools to identify novel candidate regulators for
Key Messages UNASSIGNED
Understanding the regulation of
The Lewis (Le) blood group system, in contrast to the majority of blood groups, is not able to synthesize its antigens itself. It depends on the attachment of different oligosaccharides to the erythrocyte membrane, which are adsorbed from the plasma. These glycans are modified by the fucosyltransferases 2 and 3 enzymes (FUT2/3). Beside their role in defining the Lewis blood group, FUT2 and FUT3 are also known to be involved in the susceptibility and progression of various gastrointestinal pathologies, like inflammatory bowel diseases (IBD) or colorectal cancer (CRC). Even though different expression levels of

Autres résumés

Type: plain-language-summary (eng)
The Lewis (Le) blood group system, in contrast to the majority of blood groups, is not able to synthesize its antigens itself. It depends on the attachment of different oligosaccharides to the erythrocyte membrane, which are adsorbed from the plasma. These glycans are modified by the fucosyltransferases 2 and 3 enzymes (FUT2/3). Beside their role in defining the Lewis blood group, FUT2 and FUT3 are also known to be involved in the susceptibility and progression of various gastrointestinal pathologies, like inflammatory bowel diseases (IBD) or colorectal cancer (CRC). Even though different expression levels of

Identifiants

pubmed: 39135855
doi: 10.1159/000538863
pii: 538863
pmc: PMC11318966
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

225-236

Informations de copyright

© 2024 The Author(s). Published by S. Karger AG, Basel.

Déclaration de conflit d'intérêts

C.G. acts as a consultant to Inno-Train GmbH, Kronberg im Taunus, Germany, a provider of genotyping kits for molecular blood group diagnostics since 1998 and holds the European and US patents P3545102 and US20190316189 on the “determination of the genotype underlying the S-s-U-phenotype of the MNSs blood group system.” All other authors state no conflict of interest.

Auteurs

Martin Wipplinger (M)

Institute of Translational Medicine, Private University in the Principality of Liechtenstein, Triesen, Liechtenstein.

Sylvia Mink (S)

Central Medical Laboratories, Feldkirch, Austria.
Medical-Scientific Faculty, Private University of the Principality of Liechtenstein, Triesen, Liechtenstein.

Maike Bublitz (M)

Institute of Translational Medicine, Private University in the Principality of Liechtenstein, Triesen, Liechtenstein.

Christoph Gassner (C)

Institute of Translational Medicine, Private University in the Principality of Liechtenstein, Triesen, Liechtenstein.

Classifications MeSH